Orchestra BioMed has gained the CE Mark for its Moderato implantable pulse generator for treating hypertension while also serving as a pacemaker.

The system uses an implantable cardiac stimulation-based treatment for hypertension that immediately lowers the patient’s blood pressure while modulating the autonomic nervous system.

The principal investigator for the Moderato studies, Karl-Heinz Kuck, said the device has potential to be “a primary treatment” for hypertension.